The World Awake:

The impact of night time hypoglycaemia (hypos)

About The World Awake global patient survey

All statistics are based on responses from The World Awake survey. The World Awake survey was a market research study funded by Novo Nordisk A/S and supported by the International Diabetes Federation. It was conducted by Aequus Research Ltd amongst 1,107 adults (>18 years) with Type 1 diabetes (536 adults) or Type 2 diabetes (571 adults) between July-September 2013. The survey was run in seven countries: Argentina (173 respondents), Canada (170 respondents), France (171 respondents), India (173 respondents), Japan (150 respondents), Sweden (100 respondents) and the UK (170 respondents). All participants were treated with insulin and had experienced a night time hypo (also known as a night time low blood sugar event taking place while asleep) which they could self-treat in the 30 days prior to the survey. For more information, visit www.worldawake.info.

All statistics shown below are global

Roll over an individual country’s name to view its statistics. All mentions below of night time hypos refer to events which could be self-treated.

Worry about night time hypos

Roll over an individual country’s name to view its statistics. All statistics are based on responses from The World Awake survey.